Evidence map›Paper›PMID 37490472›Full record

ArticlePLOS digital health2023

A retrospective cohort analysis leveraging augmented intelligence to characterize long COVID in the electronic health record: A precision medicine framework.

Zachary H Strasser, Arianna Dagliati, Zahra Shakeri Hossein Abad, Jeffrey G Klann, Kavishwar B Wagholikar, Rebecca Mesa, Shyam Visweswaran, Michele Morris, Yuan Luo, Darren W Henderson and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLOS digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Zachary H StrasserDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0002-4846-6059
Arianna DagliatiDepartment of Electrical Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.ORCID https://orcid.org/0000-0002-5041-0409
Zahra Shakeri Hossein AbadInstitute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Jeffrey G KlannDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-2043-1601
Kavishwar B WagholikarDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Rebecca MesaDepartment of Electrical Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Shyam VisweswaranDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Michele MorrisDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Yuan LuoDepartment of Preventive Medicine, Northwestern University, Chicago, Illinois, United States of America.
Darren W HendersonCenter for Clinical and Translation Science, University of Kentucky, Lexington, Kentucky, United States of America.ORCID https://orcid.org/0000-0001-6198-1912
Malarkodi Jebathilagam SamayamuthuDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Consortium for Clinical Characterization of COVID-19 by EHR (4CE)
Gilbert S OmennDept of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics, and School of Public Health, University of Michigan, Ann Arbor, Michigan, United States of America.
Zongqi XiaDepartment of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
John H HolmesDepartment of Biostatistics, Epidemiology, and Informatics; Institute for Biomedical Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
Hossein EstiriDepartment of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Shawn N MurphyDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Massachusetts General Hospital · USUniversity of Pittsburgh · USUniversity of Pavia · ITInstitute for Medical Informatics and Biostatistics · CHNorthwestern University · USUniversity of Kentucky · USUniversity of Michigan · USUniversity of Toronto · CA

Funding

Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Leveraging electronic health records to optimize treatment selection and response in multiple sclerosisR01NS098023 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Zongqi Xia · 2016 to 2026
$4.6M
Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-typesR01AI165535 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Hossein Estiri, SHAWN N MURPHY · 2022 to 2026
$4.1M
Real-world impact of the COVID-19 pandemic in people with multiple sclerosisR01NS124882 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIA, ZONGQI · 2022 to 2024
$1.2M
NIAID NIH HHS R01 AI165535NIEHS NIH HHS P30 ES017885NINDS NIH HHS R01 NS098023NINDS NIH HHS R01 NS124882
6 · The paper itself

Abstract

Physical and psychological symptoms lasting months following an acute COVID-19 infection are now recognized as post-acute sequelae of COVID-19 (PASC). Accurate tools for identifying such patients could enhance screening capabilities for the recruitment for clinical trials, improve the reliability of disease estimates, and allow for more accurate downstream cohort analysis. In this retrospective cohort study, we analyzed the EHR of hospitalized COVID-19 patients across three healthcare systems to develop a pipeline for better identifying patients with persistent PASC symptoms (dyspnea, fatigue, or joint pain) after their SARS-CoV-2 infection. We implemented distributed representation learning powered by the Machine Learning for modeling Health Outcomes (MLHO) to identify novel EHR features that could suggest PASC symptoms outside of typical diagnosis codes. MLHO applies an entropy-based feature selection and boosting algorithms for representation mining. These improved definitions were then used for estimating PASC among hospitalized patients. 30,422 hospitalized patients were diagnosed with COVID-19 across three healthcare systems between March 13, 2020 and February 28, 2021. The mean age of the population was 62.3 years (SD, 21.0 years) and 15,124 (49.7%) were female. We implemented the distributed representation learning technique to augment PASC definitions. These definitions were found to have positive predictive values of 0.73, 0.74, and 0.91 for dyspnea, fatigue, and joint pain, respectively. We estimated that 25 percent (CI 95%: 6-48), 11 percent (CI 95%: 6-15), and 13 percent (CI 95%: 8-17) of hospitalized COVID-19 patients will have dyspnea, fatigue, and joint pain, respectively, 3 months or longer after a COVID-19 diagnosis. We present a validated framework for screening and identifying patients with PASC in the EHR and then use the tool to estimate its prevalence among hospitalized COVID-19 patients.

Identifiers

PMID37490472
PMCPMC10368277
OpenAlexW4385237265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.